Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk
about
Nutrition, epigenetics, and metabolic syndromeEpithelial cancers in the post-genomic era: should we reconsider our lifestyle?Mitochondria, bioenergetics, and the epigenome in eukaryotic and human evolutionReview paper: origin and molecular pathology of adrenocortical neoplasmsLoss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells.Epiblast/germ line hypothesis of cancer development revisited: lesson from the presence of Oct-4+ cells in adult tissues.IGF2 promotes growth of adrenocortical carcinoma cells, but its overexpression does not modify phenotypic and molecular features of adrenocortical carcinoma.IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions.Activation of Bmp2-Smad1 signal and its regulation by coordinated alteration of H3K27 trimethylation in Ras-induced senescence.The proliferating role of insulin and insulin-like growth factors in cancer.Hypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosisDistinct allelic expression patterns of imprinted IGF2 in adenocarcinoma and squamous cell carcinoma of the lung.Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation.Animal models of colitis-associated carcinogenesis.IGF-II promoter specific methylation and expression in epithelial ovarian cancer and their associations with disease characteristics.Genome-scale approaches to the epigenetics of common human disease.Pathology from evolutionary conflict, with a theory of X chromosome versus autosome conflict over sexually antagonistic traits.Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene.Energetics, epigenetics, mitochondrial genetics.Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer.Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the hostLoss of imprinting of IGF2 and the epigenetic progenitor model of cancerIGF-2 mediates intestinal mucosal hyperplasia in retinoblastoma protein (Rb)-deficient mice.Using a microfluidic device for high-content analysis of cell signalingInhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor.Isolation and characterization of novel pituitary tumor related genes: a cDNA representational difference approach.Recent advances in understanding the role of diet and obesity in the development of colorectal cancer.Biology and significance of signalling pathways activated by IGF-II.Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation.Epigenetic aspects on therapy development for gastroenteropancreatic neuroendocrine tumors.Epigenetic alteration to activate Bmp2-Smad signaling in Raf-induced senescence.Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications.Inhibitory effect of silibinin against azoxymethane-induced colon tumorigenesis in A/J mice.IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.Associations of IGF2 and DRD2 polymorphisms with laying traits in Muscovy duck.Identification of Clinical and Biologic Correlates Associated With Outcome in Children With Adrenocortical Tumors Without Germline TP53 Mutations: A St Jude Adrenocortical Tumor Registry and Children's Oncology Group Study.Genetic variation in insulin pathway genes and distal colorectal adenoma risk.Methylation status of IGF2 DMR and LINE1 in leukocyte DNA provides distinct clinicopathological features of gastric cancer patients.Specific hypomethylated CpGs at the IGF2 locus act as an epigenetic biomarker for familial adenomatous polyposis colorectal cancer.
P2860
Q26829684-436168CC-DBD2-43FF-A1B3-25431EB8668EQ28391921-54DDA087-19A6-47BC-918F-8864FA72E4E2Q33517075-D909BE47-1038-40D8-B67C-5DE7F9E46EBFQ33612954-B0BF2CE2-5D53-4B7B-9AF5-AFCAF59B53DDQ33630697-948217FE-BCD2-4A88-8C28-0FE2FFAD4A86Q33926418-2BC0CB1F-B77D-47BC-AAE2-D20955D509D8Q33999643-1544FC79-AF7D-4F0B-971E-6C3E68BEB57FQ34008641-773C8785-285A-4FA9-B589-CC17302D0A75Q34071417-3A8369A6-9971-4B85-B906-0D5F8852BC01Q34172625-EAB8BA8B-2794-4DE2-B9F4-BCF9816F09E4Q34372543-6120A9FD-84DC-4116-AFC3-ECACB0B97320Q34427314-B409FA37-C3F9-4285-8E00-8A5735F8BFFBQ34428960-5DB738D5-5AA8-4116-95F4-04C97A7DB801Q34512820-8206A1DA-145E-4829-B038-C7E16B301D3FQ34784791-5FCFAF82-C015-4F4A-A4C0-4807FA41D44BQ35024282-92A8026F-2BDA-4003-9301-77CBC2881E7CQ35092394-05C52784-D0F7-43BB-B6DF-3E97CB3A7412Q35095712-53EB0A75-3038-4A83-A5F8-3FD40E201495Q35632855-A5131266-D01A-4A10-ACE7-A92A0A1AF708Q35722177-FB187EA4-5544-499B-BF01-2F496E9A1D6CQ36257990-3128CB14-3DA0-410D-8121-7D3A7C16F013Q36813932-3ABBE6F1-2DB3-43D0-BFA8-62EECD60257CQ37454318-EA7BFCFA-F98B-49BC-99AA-E6C5DBA2B147Q37521456-E29C1CB9-DC2B-4C9D-ADB6-C2130C9A75EAQ37641786-22DFA3E1-CF42-43A6-96A2-C4281B6ECB9CQ37704785-BABD3A21-2447-4AA7-91FC-AF359508CEE2Q37850852-A39D0EFD-E149-4029-8741-46F91F3BE734Q37963987-CF2D3FC5-62A4-419F-BEDB-654E1D66A9E7Q37988364-7C368AD6-EAEE-4E9F-8C49-874A870DFC67Q37997894-948A2B23-C22E-48A7-ABDC-9CBF084867A3Q38639474-B8AAF249-6906-4326-9908-25ECC466FF60Q38785704-A55F6DAC-FE92-403E-8077-D667ECFD1F1EQ41105458-3E01B5E8-EC11-4639-89B9-3981F5B5EF9FQ45895946-816BBF67-4736-41B8-8AD2-C5F998729E54Q47105661-FC241C37-07F0-43DF-869B-D5588C576B71Q47616676-FB829CD0-9E9F-44D6-9392-0D76B74CBCB7Q47694584-E48AEB25-ABCD-4246-A7FA-37B2B10B8562Q48035332-79E3FC87-7FBE-47E5-BFCF-86BDEC762981Q54385210-27B90EBE-AF77-40FF-96DF-42B214228B19
P2860
Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Enhanced sensitivity to IGF-II ...... l proliferation and tumor risk
@ast
Enhanced sensitivity to IGF-II ...... l proliferation and tumor risk
@en
type
label
Enhanced sensitivity to IGF-II ...... l proliferation and tumor risk
@ast
Enhanced sensitivity to IGF-II ...... l proliferation and tumor risk
@en
prefLabel
Enhanced sensitivity to IGF-II ...... l proliferation and tumor risk
@ast
Enhanced sensitivity to IGF-II ...... l proliferation and tumor risk
@en
P2093
P2860
P356
P1476
Enhanced sensitivity to IGF-II ...... l proliferation and tumor risk
@en
P2093
Alexei A Sharov
Andre Levchenko
Andrew P Feinberg
Atsushi Kaneda
Chiaochun J Wang
Dan L Longo
Mark A Pearson
Minoru S H Ko
Patrick Onyango
Raymond Cheong
P2860
P304
20926-20931
P356
10.1073/PNAS.0710359105
P407
P577
2007-12-17T00:00:00Z